Blood cancer gene could be key to preventing heart failure

October 16, 2017, University of Glasgow
Blood cancer gene could be key to preventing heart failure
Credit: University of Glasgow

A new study, published today in Circulation, shows that the gene Runx1 increases in damaged heart muscle after a heart attack. An international collaboration led by researchers from the University of Glasgow, found that mice with a limited capacity to increase Runx1 gene activation were protected against the adverse changes that lead to heart failure.

Coronary heart disease is the leading cause of death worldwide and, according to figures from the British Heart Foundation, is responsible for nearly 70,000 deaths in the UK each year. Most of these deaths are caused by a (myocardial infarction) where the blood flow to the heart is acutely blocked causing irreversible damage to the .

Over the last few decades, research-led improvements in healthcare mean that more people survive a heart attack. However, the damage that has occurred to the heart muscle can predispose these patients to go on to develop – a debilitating condition in which the heart cannot pump blood around the body as well as it should.

The Runx1 gene has been extensively studied in the context of its role in leukaemia and normal blood cell development, however until now its role in the heart was unknown.

Now researchers believe that the increased expression of the Runx1 gene, which happens after a heart attack, contributes to adverse changes in the shape and pumping action of the heart.

Lead author of the study, Dr Christopher Loughrey, from the University of Glasgow's Institute of Cardiovascular and Medical Sciences, said: "We are very excited by our findings related to the Runx1 gene and myocardial infarction. Our study shows that this gene, which is well-known in relation to blood cancers, has a key part to play in after a heart attack.

Currently, more than 500,000 people across the UK have been diagnosed with heart failure and despite healthcare advances, mortality rates continue to be high. New therapeutic options to limit the development of heart failure in patients who have had a heart attack are urgently required.

Dr Loughrey said: "The study not only describes a novel role for Runx1 in the heart but also provides us with a new therapeutic strategy with great potential to improve the ability of the heart to pump and thereby limit the development of heart failure in patients who have survived a attack."

The paper, "Runx1 deficiency protects against adverse cardiac remodelling following ," is published in Circulation.

Explore further: Scientists reverse advanced heart failure in an animal model

Related Stories

Scientists reverse advanced heart failure in an animal model

October 4, 2017
Researchers have discovered a previously unrecognized healing capacity of the heart. In a mouse model, they were able to reverse severe heart failure by silencing the activity of Hippo, a signaling pathway that can prevent ...

Disparity in care for heart attack patients

August 31, 2017
Heart attack patients with long-term health conditions are significantly less likely to receive optimal care, compared to those with no long-term health problems – according to new research.

Some heart attack patients may not benefit from beta blockers

May 29, 2017
New research challenges established medical practice that all heart attack patients should be on beta blockers.

How to trick your heart into thinking you exercise

August 8, 2017
Researchers have discovered that a protein called cardiotrophin 1 (CT1) can trick the heart into growing in a healthy way and pumping more blood, just as it does in response to exercise and pregnancy. They show that this ...

Bleeding hearts predict future heart failure

June 9, 2016
The amount a heart 'bleeds' following a heart attack can predict the severity of future heart failure, according to research presented today by a University of Glasgow academic at the British Cardiovascular Conference, in ...

One in four patients develop heart failure within four years of first heart attack

May 24, 2016
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25 000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure ...

Recommended for you

The molecular mechanism underlying hypertrophic cardiomyopathy

August 20, 2018
A study led by Stanford Medicine researchers shows why so many mutations associated with hypertrophic cardiomyopathy, a heart disorder, alter a key constituent of muscle cells in a way that makes it work overtime.

Chagas disease, caused by a parasite, has spread outside of Latin America and carries a high risk of heart disease

August 20, 2018
Chagas disease, caused by infection with a parasite called Trypanosoma cruzi (T cruzi), causes chronic heart disease in about one third of those infected. Over the past 40 years, Chagas disease has spread to areas where it ...

Gout could increase heart disease risk

August 17, 2018
Having a type of inflammatory arthritis called gout may worsen heart-related outcomes for people being treated for coronary artery disease, according to new research.

Stroke patients treated at a teaching hospital are less likely to be readmitted

August 17, 2018
Stroke patients appear to receive better care at teaching hospitals with less of a chance of landing back in a hospital during the early stages of recovery, according to new research from The University of Texas Health Science ...

Cardiovascular disease related to type 2 diabetes can be reduced significantly

August 16, 2018
Properly composed treatment and refraining from cigarette consumption can significantly reduce the risk of cardiovascular disease resulting from type 2 diabetes, according to a study published in the New England Journal of ...

Genomic autopsy can help solve unexplained cardiac death

August 15, 2018
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study published in Circulation.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.